45 related articles for article (PubMed ID: 25522823)
21. PRRX1 promotes malignant properties in human osteosarcoma.
Joko R; Yamada D; Nakamura M; Yoshida A; Takihira S; Takao T; Lu M; Sato K; Ito T; Kunisada T; Nakata E; Ozaki T; Takarada T
Transl Oncol; 2021 Jan; 14(1):100960. PubMed ID: 33395745
[TBL] [Abstract][Full Text] [Related]
22. Prrx1 Fibroblasts Represent a Pro-fibrotic Lineage in the Mouse Ventral Dermis.
Leavitt T; Hu MS; Borrelli MR; Januszyk M; Garcia JT; Ransom RC; Mascharak S; desJardins-Park HE; Litzenburger UM; Walmsley GG; Marshall CD; Moore AL; Duoto B; Adem S; Foster DS; Salhotra A; Shen AH; Griffin M; Shen EZ; Barnes LA; Zielins ER; Maan ZN; Wei Y; Chan CKF; Wan DC; Lorenz HP; Chang HY; Gurtner GC; Longaker MT
Cell Rep; 2020 Nov; 33(6):108356. PubMed ID: 33176144
[TBL] [Abstract][Full Text] [Related]
23. Notch signaling.
Hess S; Pfreundschuh M; Gleissner B
J Neurosurg; 2007 Nov; 107(5):1060-1; author reply 1061-2. PubMed ID: 17977283
[No Abstract] [Full Text] [Related]
24. Neuronal Mechanisms Govern Glioblastoma Cell Invasion.
Lin X; Huang Z; Wang Y
Neurosci Bull; 2023 Jun; 39(6):1027-1030. PubMed ID: 36723779
[No Abstract] [Full Text] [Related]
25. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
Takano S; Reichert M; Bakir B; Das KK; Nishida T; Miyazaki M; Heeg S; Collins MA; Marchand B; Hicks PD; Maitra A; Rustgi AK
Genes Dev; 2016 Jan; 30(2):233-47. PubMed ID: 26773005
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional regulation of tenascin genes.
Chiovaro F; Chiquet-Ehrismann R; Chiquet M
Cell Adh Migr; 2015; 9(1-2):34-47. PubMed ID: 25793574
[TBL] [Abstract][Full Text] [Related]
27. PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours.
Takihira S; Yamada D; Osone T; Takao T; Sakaguchi M; Hakozaki M; Itano T; Nakata E; Fujiwara T; Kunisada T; Ozaki T; Takarada T
Br J Cancer; 2024 May; 130(9):1493-1504. PubMed ID: 38448751
[TBL] [Abstract][Full Text] [Related]
28. An Experimenter's Guide to Glioblastoma Invasion Pathways.
de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O
Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Tumor Invasion by the Physical Microenvironment: Lessons from Breast and Brain Cancer.
Beeghly GF; Amofa KY; Fischbach C; Kumar S
Annu Rev Biomed Eng; 2022 Jun; 24():29-59. PubMed ID: 35119915
[TBL] [Abstract][Full Text] [Related]
30. Paired related homeobox 1 is associated with the invasive properties of glioblastoma cells.
Sugiyama M; Hasegawa H; Ito S; Sugiyama K; Maeda M; Aoki K; Wakabayashi T; Hamaguchi M; Natsume A; Senga T
Oncol Rep; 2015 Mar; 33(3):1123-30. PubMed ID: 25522823
[TBL] [Abstract][Full Text] [Related]
31. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
32. POFUT1 acts as a tumor promoter in glioblastoma by enhancing the activation of Notch signaling.
Li Q; Wang J; Ma X; Wang M; Zhou L
J Bioenerg Biomembr; 2021 Oct; 53(5):621-632. PubMed ID: 34251584
[TBL] [Abstract][Full Text] [Related]
33. Membrane proteome analysis of glioblastoma cell invasion.
Mallawaaratchy DM; Buckland ME; McDonald KL; Li CC; Ly L; Sykes EK; Christopherson RI; Kaufman KL
J Neuropathol Exp Neurol; 2015 May; 74(5):425-41. PubMed ID: 25853691
[TBL] [Abstract][Full Text] [Related]
34. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.
Natarajan M; Stewart JE; Golemis EA; Pugacheva EN; Alexandropoulos K; Cox BD; Wang W; Grammer JR; Gladson CL
Oncogene; 2006 Mar; 25(12):1721-32. PubMed ID: 16288224
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
